Tricuspid interventions: knowns and unknowns
With the collaboration of the PCR Tricuspid Focus Group
Tricuspid valve repair / replacement
Case-based Discussion
Thames Room
Anchorperson: Lukas Stolz
Spokesperson: Jörg Hausleiter
Discussants: Nina Ajmone Marsan, Rodrigo Estevez-Loureiro, Hannah Kempton, Laura Lupi
Watch this session if you want
- To hear the latest evidence from registries and randomised controlled trials in the field of transcatheter tricuspid valve intervention
- To learn more about the new Euro tricuspid regurgitation risk score
- To discuss the principal controversies in this rapidly advancing domain
Welcome and session objectives
Latest evidence for transcatheter tricuspid valve intervention: an update from current randomised controlled trials
Discussion and audience interaction
The real world - a T-TEER patient ineligible for trial recruitment
Discussion and audience interaction
Does optimal medical therapy exist for patients with tricuspid regurgitation?
Discussion and audience interaction
Should we use transcatheter tricuspid valve replacement in patients with straightforward anatomy who are eligible for T-TEER?
Charles Davidson
Discussion and audience interaction
Can we summarise all the relevant risk factors for patients with tricuspid regurgitation in a comprehensive score?
Discussion and audience interaction
Case resolution and clinical outcome
Session evaluation and key learnings
